Debra J.H. Mathews1, Robert Cook-Deegan2 and Tania Bubela3, ,
1 Johns Hopkins Berman Institute of Bioethics, 1809 Ashland Avenue, Baltimore, MD 21205, USA
2 Institute for Genome Sciences & Policy and Sanford School of Public Policy, Duke University, Box 90141, 304 Research Drive, Durham, NC 27708-0141, USA
3 School of Public Health, Edmonton Clinic Health Academy, 11405 87 Avenue, Edmonton, AB, T6G 1C9, Canada
Realizing the therapeutic potential of both stem cell and genomics research requires harnessing the respective strengths of academic, biotechnology, and pharmaceutical sectors, supported by policies and legal incentives for multisectorial collaboration. Here, we discuss issues facing these fields and lessons from the genomics sector that apply to stem cell research.